AI-CVD vs qXR-CTR
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your institution frequently performs CT scans for various indications and you aim to opportunistically screen patients for a wide array of hidden cardiovascular and multisystem disease risks without additional imaging or workflow disruption. This tool is ideal for leveraging existing CT data to provide detailed insights into coronary artery calcium, cardiac chamber volumes, and other critical anatomical measurements.
View AI-CVD →Choose qXR-CTR if…
Choose qXR-CTR if your primary need is an automated, rapid assessment of heart size and potential heart failure risk directly from chest X-ray images. This tool is best suited for environments where chest X-rays are a common diagnostic tool and you require an efficient, AI-powered solution to accurately measure the cardiothoracic ratio.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | qXR-CTR |
|---|---|---|
| Deployment | Unknown | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| FDA Status | Unknown | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
qXR-CTRBoth tools aim for seamless integration into existing workflows. However, qXR-CTR explicitly offers multilingual support on mobile and web, along with a dedicated app for multi-modality image viewing on various devices, suggesting a broader and more accessible user experience.
Clinical Value
AI-CVDAI-CVD is an FDA-cleared, comprehensive opportunistic screening platform that performs 11 different assessments for cardiovascular and multisystem diseases from existing CT scans, including CAC scoring, cardiac chamber volumetry, and bone mineral density. This offers a significantly broader range of clinical insights and early disease detection capabilities compared to qXR-CTR's more focused automated cardiothoracic ratio measurement from chest X-rays.
Pricing & Value
AI-CVDWhile both tools require contacting the vendor for pricing, AI-CVD explicitly states that it 'Requires No Extra Cost for You or Your Physician' and leverages existing CT scans. This suggests a strong value proposition by integrating into existing imaging without additional patient or physician burden, whereas qXR-CTR's pricing and value proposition remain opaque.
Enterprise Readiness
qXR-CTRqXR-CTR explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA), and offers flexible deployment options including cloud, on-premise, and hybrid. AI-CVD's compliance statements are less definitive, indicating 'likely, contact vendor' for BAA and HIPAA, and it only lists cloud deployment.
Innovation
AI-CVDAI-CVD's approach to opportunistic screening for a wide array of cardiovascular and multisystem diseases using existing CT scans, transforming routine imaging into a preventive platform, represents a significant innovation. It also received 'Breakthrough Designation' for detecting specific cardiac conditions. While qXR-CTR automates an important measurement, AI-CVD's multi-system, opportunistic screening is a more profound paradigm shift.
Support & Docs
qXR-CTRQure.ai provides explicit documentation for qXR-CTR, including a 'User's Manual' and 'Gateway User Manual,' as well as API specifications. HeartLung Corporation's AI-CVD does not have specific support or documentation details readily available in the provided facts or search results, beyond a general 'Knowledge Center'.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | qXR-CTR |
|---|---|---|
| Name | AI-CVD | qXR-CTR |
| Primary Purpose | Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. |
| Input Imaging Modality | Existing CT scans (chest and abdominal) | Chest X-ray images |
| Key Measurements/Analysis | Automated CT-derived anatomical and density-based measurements, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing. | Automated measurement of the cardiothoracic ratio (CTR). |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and qXR-CTR.